Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chinese Post-marketing Clinical Study Project Protocol for Evaluate the Safety of BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System

NCT05667285 is registered in ClinicalTrials.gov with Biotronik (Beijing) Medical Device Ltd. as lead sponsor.

NCT NCT05667285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chinese Post-marketing Clinical Study Project Protocol for Evaluate the Safety of BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
Lead sponsor
Biotronik (Beijing) Medical Device Ltd.
Phase
Observational
Overall status
Terminated
Start date
June 2, 2023
Completion date
September 27, 2024
Enrollment
122 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

in-stent stenosis (restenosis) of coronary artery stent, native coronary artery stenosis